221 related articles for article (PubMed ID: 20430601)
1. A 24-week comparison of low-dose ciclesonide and fluticasone propionate in mild to moderate asthma.
Dahl R; Engelstätter R; Trebas-Pietraś E; Kuna P
Respir Med; 2010 Aug; 104(8):1121-30. PubMed ID: 20430601
[TBL] [Abstract][Full Text] [Related]
2. A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma.
Boulet LP; Bateman ED; Voves R; Müller T; Wolf S; Engelstätter R
Respir Med; 2007 Aug; 101(8):1677-86. PubMed ID: 17448650
[TBL] [Abstract][Full Text] [Related]
3. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R
Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J
Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma.
Pedersen S; Garcia Garcia ML; Manjra A; Theron I; Engelstätter R
Pediatr Pulmonol; 2006 Oct; 41(10):954-61. PubMed ID: 16868976
[TBL] [Abstract][Full Text] [Related]
6. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma.
Buhl R; Vinkler I; Magyar P; Györi Z; Rybacki C; Middle MV; Escher A; Engelstätter R
Pulm Pharmacol Ther; 2006; 19(6):404-12. PubMed ID: 16310388
[TBL] [Abstract][Full Text] [Related]
7. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
Lee DK; Haggart K; Currie GP; Bates CE; Lipworth BJ
Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma.
Vermeulen JH; Gyurkovits K; Rauer H; Engelstätter R
Respir Med; 2007 Oct; 101(10):2182-91. PubMed ID: 17614270
[TBL] [Abstract][Full Text] [Related]
9. Similar efficacy of ciclesonide once daily versus fluticasone propionate twice daily in patients with persistent asthma.
Magnussen H; Hofman J; Staneta P; Lawo JP; Hellwig M; Engelstätter R
J Asthma; 2007 Sep; 44(7):555-63. PubMed ID: 17885859
[TBL] [Abstract][Full Text] [Related]
10. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
11. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[TBL] [Abstract][Full Text] [Related]
12. Difference between patient-reported side effects of ciclesonide versus fluticasone propionate.
van der Molen T; Foster JM; Caeser M; Müller T; Postma DS
Respir Med; 2010 Dec; 104(12):1825-33. PubMed ID: 20584595
[TBL] [Abstract][Full Text] [Related]
13. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
Derom E; Van De Velde V; Marissens S; Engelstätter R; Vincken W; Pauwels R
Pulm Pharmacol Ther; 2005; 18(5):328-36. PubMed ID: 15939311
[TBL] [Abstract][Full Text] [Related]
14. Fluticasone/Formoterol combination therapy compared with monotherapy in adolescent and adult patients with mild to moderate asthma.
Pearlman DS; LaForce CF; Kaiser K
Clin Ther; 2013 Jul; 35(7):950-66. PubMed ID: 23870606
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma.
Boulet LP; Drollmann A; Magyar P; Timar M; Knight A; Engelstätter R; Fabbri L
Respir Med; 2006 May; 100(5):785-94. PubMed ID: 16427266
[TBL] [Abstract][Full Text] [Related]
16. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
17. Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma.
Derom E; Louis R; Tiesler C; Engelstätter R; Kaufman JM; Joos GF
Eur Respir J; 2009 Jun; 33(6):1277-86. PubMed ID: 19164356
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of ciclesonide 160 and 640 microg/day in severe asthma.
Bateman ED; Cheung D; Lapa e Silva J; Göhring UM; Schäfer M; Engelstätter R
Pulm Pharmacol Ther; 2008; 21(3):489-98. PubMed ID: 18178494
[TBL] [Abstract][Full Text] [Related]
19. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
[TBL] [Abstract][Full Text] [Related]
20. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety.
Bodzenta-Lukaszyk A; Buhl R; Balint B; Lomax M; Spooner K; Dissanayake S
J Asthma; 2012 Dec; 49(10):1060-70. PubMed ID: 23102189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
